BeyondSpring Inc. Increase Decrease In Operating Lease Liability
BeyondSpring Inc. (BYSI) reported Increase Decrease In Operating Lease Liability of -$362.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- BeyondSpring Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$182.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$180.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$189.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$173.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for fiscal 2025 was -$709.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for fiscal 2024 was -$631.00K.
- BeyondSpring Inc. increase decrease in operating lease liability for fiscal 2023 was -$966.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$362.00K 10-Q · filed 2026-08-14 | -$551.00K derived: sum of 3 quarters · filed 2026-08-14 | -$724.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$180.00K 10-Q · filed 2026-05-13 | -$369.00K derived: sum of 2 quarters · filed 2026-05-13 | -$542.00K derived: sum of 3 quarters · filed 2026-05-13 | -$711.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$362.00K derived: sum of 2 quarters · filed 2026-03-25 | -$531.00K derived: sum of 3 quarters · filed 2026-08-14 | -$709.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$342.00K derived: sum of 2 quarters · filed 2026-08-14 | -$520.00K 10-Q · filed 2025-11-12 | -$682.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$347.00K 10-Q · filed 2026-08-14 | -$509.00K derived: sum of 3 quarters · filed 2026-08-14 | -$669.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$178.00K 10-Q · filed 2026-05-13 | -$340.00K derived: sum of 2 quarters · filed 2026-05-13 | -$500.00K derived: sum of 3 quarters · filed 2026-05-13 | -$657.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$322.00K derived: sum of 2 quarters · filed 2026-03-25 | -$479.00K derived: sum of 3 quarters · filed 2026-03-25 | -$631.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$317.00K derived: sum of 2 quarters · filed 2025-11-12 | -$469.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$309.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$152.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$966.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | -$1.46M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | -$7.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$239.00K derived: sum of 2 quarters · filed 2023-04-18 | -$353.00K derived: sum of 3 quarters · filed 2023-04-18 | -$518.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | -$232.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | -$346.00K derived: sum of 2 quarters · filed 2021-12-30 | -$511.00K 6-K · filed 2021-12-30 | -$644.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | -$114.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | -$279.00K 6-K · filed 2021-09-10 | -$412.00K derived: sum of 3 quarters · filed 2023-04-18 | -$600.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | -$165.00K 6-K · filed 2021-06-16 | -$298.00K derived: sum of 2 quarters · filed 2023-04-18 | -$486.00K derived: sum of 3 quarters · filed 2023-04-18 | -$623.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | -$133.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$321.00K derived: sum of 2 quarters · filed 2023-04-18 | -$458.00K derived: sum of 3 quarters · filed 2023-04-18 | -$621.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | -$188.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | -$325.00K derived: sum of 2 quarters · filed 2021-12-30 | -$488.00K 6-K · filed 2021-12-30 | |
| 2020-06-30 | -$137.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | -$300.00K 6-K · filed 2021-09-10 | ||
| 2020-03-31 | -$163.00K 6-K · filed 2021-06-16 | |||
| 2019-12-31 | -$697.00K 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |